Marc B. Bissonnette
Impact in
- Molecular Biology top 5%
- RNA modifications and cancer
- Epigenetics and DNA Methylation
- Metabolism, Diabetes, and Cancer
- Ginseng Biological Effects and Applications
- Cancer Research top 10%
- Cancer Genomics and Diagnostics
Papers in
-
- Epigenetics and DNA Methylation 3
- Metabolism, Diabetes, and Cancer 3
- RNA modifications and cancer 3
- PI3K/AKT/mTOR signaling in cancer 2
-
- Immune cells in cancer 2
- Co-authors
- Chuan He (3 shared papers)Chuanyuan Chen (2 shared papers)Yi Liu (2 shared papers)Renbao Chang (2 shared papers)Urszula Dougherty (2 shared papers)Meng Michelle Xu (2 shared papers)Dali Han (2 shared papers)Jun Liu (2 shared papers)
- Journals
- Molecular Cell (2 papers)Cancer Chemotherapy and Pharmacology (1 paper)Gastroenterology (1 paper)Cell chemical biology (1 paper)The American Journal of Chinese Medicine (1 paper)
- Partner nations
- United StatesChinaTaiwan
In The Last Decade
Marc B. Bissonnette
12 papers receiving 1.9k citations
Marc B. Bissonnette's Hit Papers
Peers
Comparison fields: 5 of 77
- Molecular Biology 1.4k
- Cancer Research 180
- Immunology 201
- Oncology 221
- Hepatology 24
Countries citing papers authored by Marc B. Bissonnette
This map shows the geographic impact of Marc B. Bissonnette's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc B. Bissonnette with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc B. Bissonnette more than expected).
Fields of papers citing papers by Marc B. Bissonnette
This network shows the impact of papers produced by Marc B. Bissonnette. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc B. Bissonnette. The network helps show where Marc B. Bissonnette may publish in the future.
Co-authors
The 25 scholars most cited alongside Marc B. Bissonnette, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Anti-tumour immunity controlled through mRNA m6A methylation and YTHDF1 in dendritic cells Hit paper breakdown → | 2019 | 801 |
| 2 | 2017 | 298 | |
| 3 | 2021 | 232 | |
| 4 | YTHDF2 orchestrates tumor-associated macrophage reprogramming and controls antitumor immunity through CD8+ T cells Hit paper breakdown → | 2023 | 179 |
| 5 | 2020 | 164 | |
| 6 | 2014 | 82 | |
| 7 | 2011 | 65 | |
| 8 | 2015 | 49 | |
| 9 | 2018 | 15 | |
| 10 | 2022 | 12 | |
| 11 | 2022 | 4 | |
| 12 | 2003 | 3 | |
| 13 | A pharmacodynamic study of sirolimus and metformin in patients with advanced solid tumors | 2018 | 0 |
About Marc B. Bissonnette
Marc B. Bissonnette is a scholar working on Molecular Biology, Immunology, Oncology, Cancer Research and Nuclear Energy and Engineering, having authored 13 papers that have together received 1.9k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (3 papers), Metabolism, Diabetes, and Cancer (3 papers), RNA modifications and cancer (3 papers), PI3K/AKT/mTOR signaling in cancer (2 papers), Immune cells in cancer (2 papers), Cancer, Hypoxia, and Metabolism (1 paper), Cancer Immunotherapy and Biomarkers (1 paper) and Cancer Cells and Metastasis (1 paper). The work is most often cited by research in Molecular Biology (1.4k citations), Cancer Research (180 citations), Immunology (201 citations), Oncology (221 citations) and Hepatology (24 citations). Marc B. Bissonnette has collaborated with scholars based in United States, China and Taiwan. Frequent co-authors include Chuan He, Chuanyuan Chen, Yi Liu, Renbao Chang, Urszula Dougherty, Meng Michelle Xu, Dali Han, Jun Liu, Xiaona Huang and Ralph R. Weichselbaum. Their work appears in journals such as Molecular Cell, Cancer Chemotherapy and Pharmacology, Gastroenterology, Cell chemical biology and The American Journal of Chinese Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.